1,000 Robotic Surgeries: Karmanos Urologic Oncologist Celebrates Milestone
Karmanos Physician-Scientist Led Clinical Trial Studies, Preceding FDA-Approval of New Targeted Inhibitor for AML Patients
Karmanos First in Michigan to Offer Lifileucel (TIL Therapy) to Treat Advanced Melanoma
Karmanos Cancer Institute Reveals New Brand Campaign, Showcasing Cancer Survivors and Local Community Businesses
Karmanos Cancer Institute Adds New Breast Surgeon and Southeast Michigan Native to Multidisciplinary Team
Three New Leaders in 2025 Pave the Way to More Cancer Treatment Discoveries at Karmanos
Head and Neck Cancer: Upcoming Symposium Unites Experts in Oncology – Register Now
Karmanos Clinical Trials Connect Newsletter: Oct. 2025
Karmanos Clinical Trials Connect Newsletter: Aug. 2025
Karmanos Multiple Myeloma Expert Graces Hour Detroit’s 2025 Top Docs Cover, List Includes Over 80 Karmanos Physicians
Last Chance to Register: Karmanos and Wayne State University’s Annual Gastrointestinal Oncology Symposium
Four Biomedical Data Scientists Join Karmanos to Advance Cancer Research